Other important pathways implicated in the pathogenesis of monogenic SLE are type 1 interferonopathies (e.g., STING, TREX1) leading to the upregulation of interferon-stimulating genes and complement deficiencies. This evidence concerns the gene STING1 and systemic lupus erythematosus.